CD33-specific chimeric antigen receptor T cells exhibit potent preclinical activity against human acute myeloid leukemia

S. S. Kenderian, M. Ruella, O. Shestova, M. Klichinsky, V. Aikawa, J. J.D. Morrissette, J. Scholler, D. Song, D. L. Porter, M. Carroll, C. H. June, S. Gill

Research output: Contribution to journalArticlepeer-review

210 Scopus citations

Fingerprint

Dive into the research topics of 'CD33-specific chimeric antigen receptor T cells exhibit potent preclinical activity against human acute myeloid leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences